Hyperkalemia in Heart Failure Hospitalizations: An Underreported Contributor to Poor Outcomes and Higher Costs in Brazil

Scritto il 28/05/2026
da Roberto Pecoits-Filho

Arq Bras Cardiol. 2026 May 22;123(3):e20250394. doi: 10.36660/abc.20250394. eCollection 2026.

ABSTRACT

Hyperkalemia is associated with poor prognosis in heart failure (HF), but its reporting in administrative data is likely suboptimal. The aim was to evaluate the frequency and impact of hyperkalemia ICD coding during HF hospitalizations in Brazil. We analyzed 3,551,738 HF hospitalizations from the DATASUS database (2008-2024). ICD codes were used to identify hyperkalemia. Logistic and Cox regression analyses assessed associations between comorbidities, outcomes, and resource utilization. Only 491 hospitalizations (0.014%) were coded for hyperkalemia. These patients were older (mean 70.3 vs. 66.6 years) and had higher rates of chronic kidney disease, diabetes, and cardiovascular disease. Hyperkalemia was associated with increased in-hospital mortality (25% vs. 10%), ICU admissions (17% vs. 11%), dialysis (11% vs. 1%), and longer ICU stays (9.45 vs. 5.36 days). Average costs were 59% higher (2,402 vs. 1,512 BRL). Hyperkalemia is severely underreported in Brazilian HF hospitalizations, despite being a clear marker of clinical severity and higher resource use. Improved awareness and coding may support better outcomes and planning.

PMID:42207122 | DOI:10.36660/abc.20250394